Figure 3From: Determinants of access to experimental antiretroviral drugs in an Italian cohort of patients with HIV: a multilevel analysis Regimen changes involving an experimental antiretroviral through clinical trials or expanded access programs (EAP) in each clinical centre.Back to article page